HOME CONSORTIUM LIMITED (HMC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HMC - HOME CONSORTIUM LIMITED

Year End: June
GICS Industry Group : Real Estate
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.73

04 Oct
2022

0.320

OPEN

$4.47

7.26%

HIGH

$4.74

314,553

LOW

$4.47

TARGET
$6.018 27.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AMP . ASX . BLA . PDL . CGF . GBST . HGG . IFL . IRE . MFG . PPS . PPT . PTM . CVW . JHG . CL1 . ENN . KAM . KSL . BVS . PNI . MOE . NWL . LNK . GBT . HUB . NGI . GDG . AEF . PAC . MQG . MAF . MAI . GDC . GQG . TDI . RZI . QAL . AVC .
FNARENA'S MARKET CONSENSUS FORECASTS
HMC: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx 26.3 23.7 xxx
DPS (cps) xxx 12.0 12.0 xxx
EPS Growth xxx N/A - 10.1% xxx
DPS Growth xxx - 84.9% 0.0% xxx
PE Ratio xxx N/A 20.4 xxx
Dividend Yield xxx N/A 2.5% xxx
Div Pay Ratio(%) xxx 45.6% 50.7% xxx

Dividend yield today if purchased 3 years ago: 250.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.48

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 01/09 - ex-div 6c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 202020212022
EPS Basic xxxxxx26.3
DPS All xxxxxx12.0
Sales/Revenue xxxxxx78.7 M
Book Value Per Share xxxxxx282.4
Net Operating Cash Flow xxxxxx18.5 M
Net Profit Margin xxxxxx98.17 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022
Return on Capital Employed xxxxxx9.95 %
Return on Invested Capital xxxxxx8.53 %
Return on Assets xxxxxx8.15 %
Return on Equity xxxxxx9.95 %
Return on Total Capital xxxxxx4.68 %
Free Cash Flow ex dividends xxxxxx-19.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

25/08/2022

3

Neutral

$5.82

23.04%

FY22 results were ahead of Credit Suisse estimates. No FY23 guidance was provided, with Home Consortium alluding to the "unpredictable nature" of transaction income. A flat distribution in FY23 is guided, at $0.12.

Credit Suisse believes the challenge is in replacing $28m in trading profits and the $30.6m in acquisition fees derived in FY22. The broker does not rule out achieving important transaction activity but lowers estimates to reflect softer growth.

Neutral maintained. Target is reduced to $5.82 from $6.16.

FORECAST
Credit Suisse forecasts a full year FY23 dividend of 12.00 cents and EPS of 27.00 cents.
Credit Suisse forecasts a full year FY24 dividend of 12.00 cents and EPS of 31.00 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx xx xxxxxxx xxxx xxxx

$xx.xx

(xx/xx/xxxx)

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

HMC STOCK CHART